From Our 2010 Archives
Early Tamiflu Might Benefit Transplant Patients With H1N1 Flu
Latest Cold and Flu News
THURSDAY, July 8 (HealthDay News) -- Early treatment with antiviral drugs appears to help prevent serious illness and death in organ transplant patients with H1N1 swine flu, researchers say.
Because they take immune system-suppressing drugs in order to prevent rejection of their new organs, transplant recipients may be at increased risk for flu virus infection and related complications, the authors of the new study explained in a news release about the study, which was published online July 8 in The Lancet Infectious Diseases.
The study included 237 transplant recipients (154 adults, 83 children) in Canada, Europe and the United States who were infected with the pandemic H1N1 influenza strain A between April and December 2009. The patients had received their transplants a median of 3.6 years before being infected with H1N1 swine flu.
The Latest on
- Allergic Skin Disorders
- Bacterial Skin Diseases
- Bites and Infestations
- Diseases of Pigment
- Fungal Skin Diseases
- Medical Anatomy and Illustrations
- Noncancerous, Precancerous & Cancerous Tumors
- Oral Health Conditions
- Papules, Scales, Plaques and Eruptions
- Scalp, Hair and Nails
- Sexually Transmitted Diseases (STDs)
- Vascular, Lymphatic and Systemic Conditions
- Viral Skin Diseases
- Additional Skin Conditions